These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22222370)

  • 1. Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development.
    Skogastierna C; Johansson M; Parini P; Eriksson M; Eriksson LC; Ekström L; Björkhem-Bergman L
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1046-51. PubMed ID: 22222370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin inhibits the core promoter of the TXNRD1 gene and lowers cellular TrxR activity in HepG2 cells.
    Ekström L; Johansson M; Monostory K; Rundlöf AK; Arnér ES; Björkhem-Bergman L
    Biochem Biophys Res Commun; 2013 Jan; 430(1):90-4. PubMed ID: 23154180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-carcinogenic effect of statins in a rat model correlates with levels and synthesis of ubiquinone.
    Acimovic J; Lövgren-Sandblom A; Eriksson LC; Björkhem-Bergman L
    Biochem Biophys Res Commun; 2012 Aug; 425(2):348-52. PubMed ID: 22842579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
    Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
    Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: Exploring anticarcinogenic agents in a rat hepatocarcinogenesis model--focus on selenium and statins.
    Björkhem-Bergman L; Ekström L; Eriksson LC
    In Vivo; 2012; 26(4):527-35. PubMed ID: 22773564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
    Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
    Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone supplementation.
    Björkhem-Bergman L; Acimovic J; Torndal UB; Parini P; Eriksson LC
    Anticancer Res; 2010 Apr; 30(4):1105-12. PubMed ID: 20530415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sodium selenite on liver growth and thioredoxin reductase expression in regenerative and neoplastic liver cell proliferation.
    Erkhembayar S; Mollbrink A; Eriksson LC
    Biochem Pharmacol; 2012 Mar; 83(5):687-93. PubMed ID: 22177986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney.
    Crosley LK; Méplan C; Nicol F; Rundlöf AK; Arnér ES; Hesketh JE; Arthur JR
    Arch Biochem Biophys; 2007 Mar; 459(2):178-88. PubMed ID: 17291446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
    Chen GP; Yao L; Lu X; Li L; Hu SJ
    Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.
    Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C
    Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium homeostasis and induction of thioredoxin reductase during long term selenite supplementation in the rat.
    Erkhembayar S; Mollbrink A; Eriksson M; Larsen EH; Eriksson LC
    J Trace Elem Med Biol; 2011 Dec; 25(4):254-9. PubMed ID: 22033016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system.
    Selenius M; Fernandes AP; Brodin O; Björnstedt M; Rundlöf AK
    Biochem Pharmacol; 2008 Jun; 75(11):2092-9. PubMed ID: 18405881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
    Gorlatov SN; Stadtman TC
    Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-induced liver injury involves cross-talk between cholesterol and selenoprotein biosynthetic pathways.
    Kromer A; Moosmann B
    Mol Pharmacol; 2009 Jun; 75(6):1421-9. PubMed ID: 19332511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis.
    Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S
    Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
    J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.
    Sakurai A; Nishimoto M; Himeno S; Imura N; Tsujimoto M; Kunimoto M; Hara S
    J Cell Physiol; 2005 Jun; 203(3):529-37. PubMed ID: 15521073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.